Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
121.2 EUR | +1.00% | +0.46% | +53.61% |
Apr. 11 | Berenberg Reiterates UCB's Purchase Rating, Raises PT | MT |
Apr. 11 | UCB : Berenberg, Buy, raises its price target | CF |
Sales 2024 * | 5.61B 5.98B | Sales 2025 * | 6.31B 6.72B | Capitalization | 23B 24.5B |
---|---|---|---|---|---|
Net income 2024 * | 466M 496M | Net income 2025 * | 880M 937M | EV / Sales 2024 * | 4.39 x |
Net Debt 2024 * | 1.63B 1.73B | Net Debt 2025 * | 800M 852M | EV / Sales 2025 * | 3.77 x |
P/E ratio 2024 * |
49.4
x | P/E ratio 2025 * |
25.1
x | Employees | 8,767 |
Yield 2024 * |
1.16% | Yield 2025 * |
1.2% | Free-Float | 61.44% |
Latest transcript on UCB
1 day | +1.00% | ||
1 week | +3.11% | ||
Current month | +5.94% | ||
1 month | +12.69% | ||
3 months | +48.20% | ||
6 months | +54.87% | ||
Current year | +53.61% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 11-05-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 57 | 20-06-30 |
Chief Tech/Sci/R&D Officer | 63 | 17-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 16-04-27 | |
Dame Davies
BRD | Director/Board Member | 73 | 13-12-31 |
Director/Board Member | 69 | 10-04-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.88% | 2 M€ | +5.72% | ||
0.72% | 14 M€ | +5.66% | - | |
0.72% | 5 M€ | +10.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 121.2 | +1.00% | 196,717 |
24-04-18 | 120 | +0.08% | 265,450 |
24-04-17 | 119.9 | +0.46% | 269,115 |
24-04-16 | 119.4 | -0.08% | 161,950 |
24-04-15 | 119.4 | -0.99% | 284,277 |
Real-time Euronext Bruxelles, April 19, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.61% | 24.28B | |
-5.99% | 84.46B | |
+2.76% | 40.85B | |
-24.88% | 27.69B | |
-8.08% | 17.09B | |
-33.74% | 13.67B | |
-16.63% | 11.86B | |
-11.19% | 11.79B | |
-2.25% | 8.07B | |
+1.05% | 7.51B |
- Stock Market
- Equities
- UCB Stock